Assessing intestinal permeability in Crohn's disease patients using orally administered 52Cr-EDTA.
Julius Z H von MartelsArno R BourgonjeHermie J M HarmsenKlaas Nico FaberGerard DijkstraPublished in: PloS one (2019)
Orally administered and renal excreted 52Cr-EDTA may be used to assess intestinal permeability in CD and correlates with fecal calprotectin levels and bacterial species relevant to CD. This test may improve non-invasive detection of disease exacerbations and help monitor disease activity.
Keyphrases
- disease activity
- rheumatoid arthritis
- systemic lupus erythematosus
- end stage renal disease
- rheumatoid arthritis patients
- ankylosing spondylitis
- ejection fraction
- chronic obstructive pulmonary disease
- newly diagnosed
- chronic kidney disease
- juvenile idiopathic arthritis
- endothelial cells
- cystic fibrosis
- peritoneal dialysis
- nk cells
- patient reported
- real time pcr